BRS1-FM1-PM1 - Amino-Acid Availability & Prioritisation
(Neurotransmitter Protein Requirements)
1. Mission & Overview
Mission
Ensure meal-level protein supply delivers the amino-acid foundation neurotransmitter pathways depend on.
Overview
Determines how completely meals supply the indispensable amino acids (protein building blocks the body cannot make on its own) that downstream pathways convert into dopamine, noradrenaline, and serotonin. Protein quantity, quality, and distribution across the day set the ceiling for neurotransmitter precursor availability, independent of blood–brain barrier transport or conversion efficiency. When intake is inconsistent or incomplete, every downstream monoaminergic pathway inherits that shortfall.
- Provides the amino-acid foundation for dopamine, noradrenaline, and serotonin synthesis.
- Sets the ceiling for precursor supply through meal-level protein quantity and quality.
- Depends on consistent, complete indispensable amino-acid coverage across the day.
2. Primary Biological Effects
↑ amino-acid pool sufficiency; ↑ neurotransmitter-relevant amino-acid prioritisation
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Rationale: Meal-level amino-acid sufficiency and coverage of neurotransmitter-relevant substrates (including tyrosine and tryptophan) may support the precursor pool underlying catecholaminergic and serotonergic attention pathways relevant to ADHD; competitive LAT1 transport and downstream signalling are handled by sibling PMs (PM2–PM4), not substrate availability alone.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Rationale: Dietary tyrosine availability contributes to catecholamine precursor supply relevant to motivation and drive in ADHD populations; this PM governs amino-acid pool sufficiency only, not dopaminergic signalling or reward regulation (PM3/PM4).
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low
- Rationale: Dietary tryptophan and broader indispensable amino-acid coverage may influence serotonergic precursor availability relevant to emotional regulation in ADHD; serotonin signalling and conversion belong on BRS1-FM1-PM4.
- Key References:
- Evidence Confidence: Low
4. Levers
Intervention Profile
Intervention Dominance: Diet-Dominant
- Tyrosine ← poultry, eggs, fish, soy
- Tryptophan ← poultry, eggs, dairy, oats
- Complete protein sources ← eggs, fish, dairy, poultry, soy
- Complementary plant-protein pairing ← legumes + grains; beans + rice; lentils + whole grains
- Distributed protein intake ← protein-containing meals across the day
- Protein-rich mixed meals ← protein paired with fibre-rich whole foods
- complementary protein pairing
- complete protein sources
- meal-level protein distribution
-
Complete essential amino-acid supply ← eggs, fish, dairy, meat, soy, legumes, grains
-
Tryptophan ← eggs, dairy, fish, poultry, soy, pumpkin seeds
-
Phenylalanine and tyrosine ← dairy, meat, fish, eggs, soy, legumes, nuts, seeds
1. Food Preparation & Delivery ONLY
- Regular meal timing supporting amino-acid availability across the day (Evidence:Human Mechanistic) [Walrand & Boirie, 2005]
- Sufficient protein at main meals to maintain amino-acid availability throughout the day (Evidence:Human Mechanistic) [Walrand & Boirie, 2005]
- Use complementary protein pairing and distributed protein across meals to support amino-acid availability — see Eggs — Synergies, Oats — Synergies.
- Best prepared with gentle cooking to preserve nutrients and prevent formation of advanced glycati… — see Chicken — Preparation.
- Prefer complementary plant-protein pairing — legumes + grains; beans + rice; lentils + whole grains.
- Prefer gentle or moist-heat cooking methods (baking, steaming, stewing) to help preserve EPA/DHA… — see Mackerel — Preparation.
5. Mechanistic Basis
Summary
Neurotransmitter-relevant biology depends first on the availability of sufficient dietary amino-acid substrate. Before transport, synthesis, signalling, or recycling can occur, meals must establish an adequate and appropriately balanced amino-acid pool capable of supporting downstream neural pathways.
(Amino-acid pool sufficiency)
Protein quantity and distribution influence the size and stability of the amino-acid pool available to the body throughout the day. Sparse protein intake, prolonged gaps between protein-containing meals, or chronically low amino-acid availability may reduce the substrate available to downstream neurotransmitter-related processes.
This mechanism therefore focuses on meal-level amino-acid sufficiency rather than isolated nutrient supplementation or acute precursor loading.
(Protein quality and amino-acid coverage)
Protein quality influences whether the dietary pattern provides adequate coverage of indispensable amino acids and neurotransmitter-relevant substrates → [Mariotti et al., 2019]
Complete protein sources, complementary plant-protein combinations, and deliberate meal construction help reduce the likelihood of chronic amino-acid shortfalls and support broader neurotransmitter-relevant amino-acid availability.
Within BRS1, particular attention is given to amino acids such as tyrosine and tryptophan because of their relevance to catecholaminergic and serotonergic pathways. The role of this PM, however, is to establish adequate substrate availability rather than directly regulate neurotransmitter production.
(Boundaries of the mechanism)
This PM governs amino-acid availability and prioritisation only.
Competitive transport of amino acids across the blood–brain barrier, including LNAA competition and transport bias, is handled by BRS1-FM1-PM2 - LAT1 Competitive Transport Modulation → [Fernstrom, 2013]
Enzymatic conversion of amino acids into neurotransmitters depends on downstream cofactors and regulatory mechanisms represented elsewhere within BRS1 and BRS2.
(Integration within BRS1)
This PM establishes the meal-level amino-acid substrate context required for downstream neurotransmitter-related processes. It operates within the shared amino-acid quality and balance constraints represented by BRS1(KC1) - Amino Acid Quality & Competitive Balance, providing the foundational amino-acid environment required for subsequent transport, conversion, signalling, and regulatory processes.
5.1 Evidence Highlights
Introduction/Summary
The core biology of amino-acid availability is well established. The studies below do not redefine this mechanism; they highlight practical protein-adequacy findings that refine how meal-level substrate sufficiency is interpreted.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: The pattern of protein intake across the day may influence how effectively dietary amino acids are utilised; meal-level distribution and source quality can affect tissue retention and amino-acid availability [Walrand & Boirie, 2005].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Larger protein boluses can sustain positive whole-body protein balance for several hours, indicating that amino-acid sufficiency depends on quantity, quality, and dietary pattern rather than rigid per-meal distribution rules [Trommelen et al., 2023].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Digestible Indispensable Amino Acid Score (DIAAS) evaluates protein quality by digestible indispensable amino-acid content, supporting interpretation of sufficiency as a function of quality and coverage rather than grams alone [Moughan & Lim, 2024].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Complementary plant-protein combinations can improve indispensable amino-acid coverage across the diet, reinforcing amino-acid adequacy as a dietary-pattern property [Moughan & Lim, 2024]; [Mariotti et al., 2019].
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
BRS1-FM1-PM1 — Amino-Acid Availability & Prioritisation ↓ BRS1-FM1-PM2 — LAT1 Competitive Transport Modulation ↓ BRS1-FM1-PM3 — Noradrenergic Signalling BRS1-FM1-PM4 — Serotonergic Signalling Regulation
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS2(FM1) — Methylation Cycle Efficiency — methylation Cycle Efficiency
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS1-FM1-PM2 - LAT1 Competitive Transport Modulation
- BRS1-FM1-PM3 - Noradrenergic Signalling
- BRS1-FM1-PM4 - Serotonergic Signalling Regulation
7. Scoreable Inputs & Modulation Signals
This PM is scoreable through food-state and nutrient signals relevant to amino-acid availability and prioritisation.
| Input Category | Example Inputs | PM1 Relevance |
|---|---|---|
| Functional Property Potentials | complete_protein_context; meal_protein_distribution; eaa_coverage | May support amino-acid pool sufficiency and prioritisation. |
| Realised Functional States | balanced_protein_meal; complementary_protein_pairing | Represent meal-pattern states relevant to this PM. |
| Preparation Transformations | complementary_protein_pairing; minimally_processed_sources | May preserve protein-quality and meal-matrix effects. |
8. References
- Mariotti et al. (2019) — Dietary Protein and Amino Acids in Vegetarian Diets
- Fernstrom (2013) — LNAA Transport and Brain Neurochemistry
- Wang et al. (2019) — Path Analysis for a Case-Control Study
- Aquili (2020) — Role of Tryptophan and Tyrosine in Executive Function and Reward Processing
- Reimherr & Ward (1987) — An Open Trial of L-tyrosine in the Treatment of Attention Deficit Disorder,
- Oades (2010) — Role of Serotonin in Attention-Deficit Hyperactivity Disorder (ADHD)
- Briguglio et al. (2018) — A Narrative Review on Current Knowledge
- Walrand & Boirie (2005) — Optimizing Protein Intake in Aging
- Trommelen et al. (2023) — Anabolic Response to Protein Ingestion
- Moughan & Lim (2024) — Digestible Indispensable Amino Acid Score (DIAAS)